Logo image of XTRA.CA

XTRACT ONE TECHNOLOGIES INC (XTRA.CA) Stock Fundamental Analysis

TSX:XTRA - Toronto Stock Exchange - CA98422Q1063 - Common Stock - Currency: CAD

0.53  +0.14 (+34.18%)

Fundamental Rating

3

Overall XTRA gets a fundamental rating of 3 out of 10. We evaluated XTRA against 12 industry peers in the Aerospace & Defense industry. XTRA has a bad profitability rating. Also its financial health evaluation is rather negative. XTRA shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year XTRA has reported negative net income.
In the past year XTRA has reported a negative cash flow from operations.
XTRA had negative earnings in each of the past 5 years.
XTRA had a negative operating cash flow in each of the past 5 years.
XTRA.CA Yearly Net Income VS EBIT VS OCF VS FCFXTRA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -60.41%, XTRA is doing worse than 66.67% of the companies in the same industry.
Looking at the Return On Equity, with a value of -157.17%, XTRA is in line with its industry, outperforming 58.33% of the companies in the same industry.
Industry RankSector Rank
ROA -60.41%
ROE -157.17%
ROIC N/A
ROA(3y)-116.76%
ROA(5y)-84.37%
ROE(3y)-154.33%
ROE(5y)-107.75%
ROIC(3y)N/A
ROIC(5y)N/A
XTRA.CA Yearly ROA, ROE, ROICXTRA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

The Gross Margin of XTRA (64.29%) is better than 100.00% of its industry peers.
The Profit Margin and Operating Margin are not available for XTRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XTRA.CA Yearly Profit, Operating, Gross MarginsXTRA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

3

2. Health

2.1 Basic Checks

XTRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, XTRA has more shares outstanding
Compared to 5 years ago, XTRA has more shares outstanding
The debt/assets ratio for XTRA has been reduced compared to a year ago.
XTRA.CA Yearly Shares OutstandingXTRA.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
XTRA.CA Yearly Total Debt VS Total AssetsXTRA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

XTRA has an Altman-Z score of -6.15. This is a bad value and indicates that XTRA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -6.15, XTRA is doing worse than 66.67% of the companies in the same industry.
A Debt/Equity ratio of 0.14 indicates that XTRA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.14, XTRA is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z -6.15
ROIC/WACCN/A
WACC9.32%
XTRA.CA Yearly LT Debt VS Equity VS FCFXTRA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

XTRA has a Current Ratio of 1.32. This is a normal value and indicates that XTRA is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.32, XTRA is doing good in the industry, outperforming 75.00% of the companies in the same industry.
XTRA has a Quick Ratio of 1.32. This is a bad value and indicates that XTRA is not financially healthy enough and could expect problems in meeting its short term obligations.
XTRA has a Quick ratio of 0.84. This is in the better half of the industry: XTRA outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.84
XTRA.CA Yearly Current Assets VS Current LiabilitesXTRA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

7

3. Growth

3.1 Past

XTRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.68%, which is quite good.
XTRA shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.22%.
XTRA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 147.42% yearly.
EPS 1Y (TTM)18.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)29.22%
Revenue growth 3Y147.42%
Revenue growth 5YN/A
Sales Q2Q%-26%

3.2 Future

The Earnings Per Share is expected to grow by 29.40% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 35.03% on average over the next years. This is a very strong growth
EPS Next Y33.33%
EPS Next 2Y32.29%
EPS Next 3Y29.4%
EPS Next 5YN/A
Revenue Next Year0.82%
Revenue Next 2Y37.43%
Revenue Next 3Y35.03%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
XTRA.CA Yearly Revenue VS EstimatesXTRA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
XTRA.CA Yearly EPS VS EstimatesXTRA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2024 2025 2026 2027 0 -0.05 -0.1 -0.15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

XTRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XTRA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XTRA.CA Price Earnings VS Forward Price EarningsXTRA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XTRA.CA Per share dataXTRA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 0.06

4.3 Compensation for Growth

XTRA's earnings are expected to grow with 29.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.29%
EPS Next 3Y29.4%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XTRA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XTRACT ONE TECHNOLOGIES INC

TSX:XTRA (8/7/2025, 7:00:00 PM)

0.53

+0.14 (+34.18%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)06-05 2025-06-05/amc
Earnings (Next)10-22 2025-10-22
Inst Owners0.36%
Inst Owner ChangeN/A
Ins Owners0.52%
Ins Owner ChangeN/A
Market Cap126.74M
Analysts82.5
Price Target0.92 (73.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-22.55%
Min EPS beat(2)-96.08%
Max EPS beat(2)50.98%
EPS beat(4)3
Avg EPS beat(4)-10.29%
Min EPS beat(4)-96.08%
Max EPS beat(4)50.98%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.37%
Min Revenue beat(2)-34.03%
Max Revenue beat(2)-2.71%
Revenue beat(4)1
Avg Revenue beat(4)-16.83%
Min Revenue beat(4)-38.64%
Max Revenue beat(4)8.05%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-24.94%
Revenue NY rev (1m)-15.64%
Revenue NY rev (3m)-15.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.85
P/FCF N/A
P/OCF N/A
P/B 18.55
P/tB 60.33
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.07
BVpS0.03
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -60.41%
ROE -157.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.29%
FCFM N/A
ROA(3y)-116.76%
ROA(5y)-84.37%
ROE(3y)-154.33%
ROE(5y)-107.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.84
Altman-Z -6.15
F-Score3
WACC9.32%
ROIC/WACCN/A
Cap/Depr(3y)9.49%
Cap/Depr(5y)20.64%
Cap/Sales(3y)2.06%
Cap/Sales(5y)21.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y33.33%
EPS Next 2Y32.29%
EPS Next 3Y29.4%
EPS Next 5YN/A
Revenue 1Y (TTM)29.22%
Revenue growth 3Y147.42%
Revenue growth 5YN/A
Sales Q2Q%-26%
Revenue Next Year0.82%
Revenue Next 2Y37.43%
Revenue Next 3Y35.03%
Revenue Next 5YN/A
EBIT growth 1Y9.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year57.3%
EBIT Next 3Y36.71%
EBIT Next 5YN/A
FCF growth 1Y42.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.42%
OCF growth 3YN/A
OCF growth 5YN/A